Argonaut Therapeutics Limited
- Company number
- 09993166
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 8 Feb 2016
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Ingenox Therapeutics Limited (2 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Prof Nicholas Barrie La Thangue | Ownership Of Shares 25 To 50 Percent | 6 Apr 2016 | 27 Sep 2018 |
| Oxford Sciences Innovation Plc | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
6 Apr 2016 | 22 Dec 2022 |
| Ingenox Therapeutics Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
22 Dec 2022 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | - | £1,230 | 0 |
| 31 Dec 2024 | - | £98,540 | 0 |
| 28 Feb 2018 | £336,667 | £381,868 | 4 |
| 28 Feb 2017 | £117,528 | £164,301 | 4 |
Connections
Owned by
Argonaut Therapeutics Limited → Ingenox Therapeutics Limited
Companies at the same address
- Celleron Therapeutics Limited (05162047)
- Ingenox Therapeutics Limited (14127227)
- Prophase Development Limited (05167257)